ANNEX I, Regulation (EU) 2024/2745

In force

Please answer each of the questions below. If the answer to any of the questions is ‘yes’, please provide further requested details on relevant interests, as appropriate.

If you do not do so, your declaration of interests form will be considered incomplete and, therefore, you will be excluded from joint work carried out in line with Regulation (EU) 2021/2282.

First name:

Family name:

Organisation/company (where applicable):

Country:

Job title in the organisation/company (where applicable):

Type of activity (choose one or several, as appropriate):

Representative in the Coordination Group

Representative in the subgroup on joint clinical assessments

Representative in the subgroup on joint scientific consultations

Representative in the subgroup on the identification of emerging health technologies

Representative in the subgroup on development of methodological and procedural guidance

Patient

Clinical expert

Other relevant expert

Q1.1. Are you or were you employed by a health technology developer:

within the past 5 years in an executive role, such as president/vice president, chief executive officer, chief scientific officer, executive director/director/associate director (Question 1.1a);

within the past 3 years in a role involving horizontal responsibility other than executive role (Question 1.1b);

within the past 3 years in a role involving individual product responsibility (Question 1.1c)?

‘employed by a health technology developer’ means any form of occupation, part-time or full-time, paid or unpaid, in a health technology developer.

‘horizontal responsibility’ means support activities for multiple health technologies across one or several therapeutic areas/full product range, such as pharmacovigillance, regulatory affairs, statistical methodology.

yes | no

□ | □

Function | Time period (from… until month/year) | Name of the health technology developer | Role/area of activity | Therapeutic area(s) (where relevant)

Q1.1a. Executive role (within the past 5 years)

Q1.1b. Horizontal responsibility other than executive role (within the past 3 years)

Function | Time period (from… until month/year) | Name of the health technology developer | Name of the health technology(ies) and the respective therapeutic indication(s)

Q1.1c. Individual product responsibility (within the past 3 years)

Q1.2. Are you or were you within the past 3 years employed in a role involving individual product responsibility by a company or organisation, to which a health technology developer has outsourced its activities on a contractual basis, such as clinical research, regulatory affairs, health technology assessment, marketing or sales?

‘employed by a company or organisation’ means any form of occupation, part-time or full-time, paid or unpaid, in a company or organisation.

yes | no

□ | □

Name of the company /organisation of employment | Time period (from … until month/year) | Name of the health technology developer | Name of the health technology(ies) and the respective therapeutic indication(s)

Q2. Do you currently, or did you within the past 3 years, provide advice to or conduct research including writing articles for a health technology developer regardless of contractual arrangements or any form of remuneration?

This question does not cover:

advice provided to a health technology developer on behalf of a national or regional authority or body. Such activity is not to be declared;

employment in consultancy companies or contract research organisations providing advice to health technology developers. Such activity is to be declared under Question 1.2 (‘Employment’);

participation in an advisory board, steering committee, executive committee in the role of providing advice/expressing opinions on the (future) strategy, direction or development activities of a health technology developer. Such activity is to be declared under Question 3 (‘Strategic advisory role’);

providing presentations or training courses. Such activity is to be declared under Question 4.2 (‘Financial interests’) under the conditions specified therein;

conducting clinical trials, clinical investigations or performance studies where you acted as a principal investigator or investigator. Such activity is to be declared under Question 5 (‘Principal investigator and investigator’).

yes | no

□ | □

Type of consultancy | Time period (from… until month/year) | Name of the health technology developer | Name of the health technology(ies) and the respective therapeutic indication(s)

Q2a. Individual product related

Type of consultancy | Time period (from… until month/year) | Name of the health technology developer | General role/area of activity | Therapeutic area(s) (where relevant)

Q2b. Horizontal

Q3. Do you currently, or did you within the past 3 years, participate in a(n) (scientific) advisory board/steering committee/executive committee in the role of providing advice/expressing opinions on the (future) strategy, direction or development activities of a health technology developer, regardless of contractual arrangements or any form of remuneration?

This question does not cover:

involvement in data monitoring committees. Such activity is to be declared under Question 5 (‘Principal investigator and investigator’);

non-remunerated participation in community advisory boards or other similar entities that aim at patients being able to provide their objective input to research and development of health technologies. Such activity is not to be declared.

yes | no

□ | □

Type of role | Time period (from… until month/year) | Name of the health technology developer | Name of the health technology(ies) and the respective therapeutic indication(s)

Q3a. Individual product related

Type of role | Time period (from… until month/year) | Name of the health technology developer | General role/area of activity | Therapeutic area(s) (where relevant)

Q3b. Horizontal

Q4.1. Do you currently have any of the following financial interests with a health technology developer:

(co)ownership, shares and other stocks, stock options, stock warrants, equities, bonds. This does not cover the holding of financial interests through an investment fund, pension fund or similar arrangements provided that they are diversified and independently managed;

intellectual property rights owned by you or of which you are directly a beneficiary?

yes | no

□ | □

Financial interest | Name of the health technology developer and/or the health technology

Q4.2. Do you currently, or did you within the past 3 years, benefit from:

payment by a health technology developer to provide a presentation or training course, attend a conference/seminar/event;

reimbursement by a health technology developer of expenses incurred in relation to providing a presentation or training course, attending a conference/seminar/event?

This question does not cover:

payment(s)/reimbursement(s) of expenses of a cumulative total value below EUR 1000 from one health technology developer over the past 3 years. Such interests are not to be declared.

yes | no

□ | □

Financial interest | Payment/ reimbursement directly to you | Date of payment/ reimbursement | Name of the health technology developer | Therapeutic area(s) (where relevant)

Yes | No | | |

□ | □

Q5. Do you currently, or did you within the past 3 years, act as a principal investigator or an investigator in a clinical trial, observation study, clinical investigation or performace study?

yes | no

□ | □

Time period (from… until month/year) | Name of the sponsor health technology developer (where relevant) | Name of the health technology(ies) and the respective therapeutic indication(s)

Q6. Are you currently (co)chair, president, director, treasurer of an organisation/institution that during the current financial year or during the most recent financial year closed received direct funding from a health technology developer or several health technology developers?

This question does not cover:

funding of national or regional authorities or bodies by fees from health technology developer. Such interests are not to be declared;

funding for the organisation of non-remunerated community advisory boards or other similar entities that aim at patients being able to provide their objective input to research and development of health technologies. Such interests are not to be declared.

yes | no

□ | □

Organisation/ institution | Registration number in the Transparency Register (where applicable) | Name of the health technology developer(s) | Current financial year | Most recent financial year closed

Yes | No | Yes | No

□ | □ | □ | □

Q7. Do your immediate family members have interests referred to in Questions 1.1a, 1.1b, 1.1c, 1.2 (‘Employment’) and 4.1 (‘Financial interests’)?

‘immediate family member’ means the individual’s spouse, children and parents. ‘Spouse’ includes a partner with whom the individual has a registered non marital regime.

‘children’ means the children that the individual and the spouse have in common, the individual’s own children and the spouse’s own children.

yes | no

□ | □

Type of interest declared | Name of the health technology developer and/or the health technology

Do you have any additional information relevant to the joint work that you would like to disclose? | yes | no

□ | □

Please provide the description here (please do not provide any personal data of other individuals):